2024/06/27 08:06:40 | |
---|---|
Price | |
4.459 EUR | |
Difference | 0.00% (0.00) |
ISIN | US67113Y6032 |
Symbol | CHFS |
Exchange | Stuttgart |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 3 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 3.934 EUR (57) |
Ask (Ask size) | 4.375 EUR (57) |
Open | 4.459 EUR |
High | 4.459 EUR |
Low | 4.459 EUR |
Close (prev. day) | 4.459 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 2 |
Last size | 0 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/09/27 | Global Equity Ratings | ||
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings |
2024/06/27 08:06:40 | |
---|---|
Price | |
4.459 EUR | |
Difference | 0.00% (0.00) |
ISIN | US67113Y6032 |
Symbol | CHFS |
Exchange | Stuttgart |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 3 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 3.934 EUR (57) |
Ask (Ask size) | 4.375 EUR (57) |
Open | 4.459 EUR |
High | 4.459 EUR |
Low | 4.459 EUR |
Close (prev. day) | 4.459 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 2 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | +750.95% | +91.37% | -98.73% |
Perf (abs.) | +137.73 | +74.52 | -12,163.94 |
Beta | -1.43 | -0.41 | 1.57 |
Volatility | 539.93 | 388.30 | 433.54 |
Ø price 5 days | Ø volume 5 days (pcs.) | 36.250 EUR (51) |
Ø price 30 days | Ø volume 30 days (pcs.) | 12.109 EUR (11) |
Ø price 100 days | Ø volume 100 days (pcs.) | 12.684 EUR (53) |
Ø price 250 days | Ø volume 250 days (pcs.) | 28.586 EUR (25) |
YTD High | date | 156.065 EUR (2024/06/27) |
YTD Low | date | 4.172 EUR (2024/05/02) |
52 Weeks High | date | 156.065 EUR (2024/06/27) |
52 Weeks Low | date | 4.172 EUR (2024/05/02) |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer